What if we could replace diseased or damaged organs and other body parts with new lab-created versions? How might transplanting tissue from other species help the critical shortage of human transplant organs? Tune in to listen to two noted experts in regenerative therapeutics and xenotransplantation (transplanting organs between members of different species). Learn more from these experts as they discuss innovations, future opportunities, challenges, ethical and legal issues, and the public’s perception of these new therapies.
Julie Allickson, Ph.D., the Michael S. and Mary Sue Shannon Family Director for Regenerative Medicine and the Otto Bremer Trust Director of Biomanufacturing and Product Development in the Mayo Clinic Center for Regenerative Biotherapeutics